gene_symbol
MS4A1
hgnc_id
HGNC:7315
binding_type
antigen recognition
cytotoxicity
YES
cytotoxicity_type
DIRECT
cytotoxicity_mechanism
Glofitamab bridges CD20 on target B cells and CD3 on T cells, forming an immunologic synapse that activates T cells to kill CD20+ cells via perforin/granzyme-mediated cytotoxicity.
enzyme_product
Off
epitope
Off
variant
Off
isoform
Off
hla_specific
Off
gated
Off
other_modifier
B-cell surface antigen; bispecific has two CD20-binding arms (2:1 CD20:CD3 valency)
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT05798156
disease_id_num_tar_ref
1014
drug_id_num_tar_ref
2769